EP3426284
GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.3.2017:
8.5.2024:
17710231.6
:
9.3.2037
:
GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
10.3.2017
8.5.2024
:
MedImmune Limited:
1 Francis Crick Avenue Cambridge Biomedical Campus, Cambridge CB2 0AA, GB
:
BEDNAREK, Maria, Aleksandra:
Cambridge Cambridgeshire CB21 6GH, GB
:
JERMUTUS, Lutz, Ulrich:
Cambridge Cambridgeshire CB21 6GH, GB
:
AMBERY, Philip:
Cambridge Cambridgeshire CB21 6GH, GB
:
PETRONE, Marcella:
Cambridge Cambridgeshire CB21 6GH, GB
:
201662306121 P:
10.3.2016:
US
:
EP2017055679:
10.3.2017
:
A61K 38/26, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/12